Enalapril use while Breastfeeding
Drugs containing Enalapril: Vasotec, Epaned, Vaseretic 10-25, Vaseretic, Lexxel, Vaseretic 5-12.5, Teczem
Enalapril Levels and Effects while Breastfeeding
Summary of Use during Lactation
Because of the low levels of enalapril in breastmilk, amounts ingested by the infant are small and would not be expected to cause any adverse effects in breastfed infants.
Enalapril is an inactive drug that is metabolized to the active metabolite enalaprilat. Enalaprilat is poorly absorbed orally.
Maternal Levels. One mother taking a single oral dose of enalapril 5 mg and 2 mothers taking a single dose 10 mg 3 to 45 days postpartum had undetectable enalaprilat milk levels (<0.2 mcg/L) 4 hours after a single dose; enalapril levels were not determined. The angiotensin converting enzyme activity in milk of all women was within the normal range and unchanged after the dose compared to the predose values.
A woman who had been taking oral enalapril 10 mg daily for 11 months had peak enalapril milk levels of 2 mcg/L 4 hours after a dose and peak enalaprilat levels of 0.75 mcg/L about 9 hours after the dose.
Enalapril and enalaprilat milk levels were determined in 5 women who were in the immediate postpartum period and not breastfeeding. After a single 20 mg oral dose, the average peak enalapril milk level was 1.7 mcg/L (range 0.54 to 5.9 mcg/L) at 4 to 6 hours after the dose. Enalapril was not detectable (assay limit not specified) after 4 hours in 4 of the 5 women. The average peak enalaprilat level was 1.7 mcg/L (range 1.2 to 2.3 mcg/L); peaks occurred at various times over the 24-hour period. The authors estimated that a breastfed infant would receive less than 2 mcg/day of enalaprilat. Using the peak milk level data, the estimated maximum intake of an exclusively breastfed infant would be about 0.16% of the maternal weight-adjusted dosage, half as enalaprilat.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
None reported in 4 breastfed infants whose mothers were taking oral enalapril 5 to 10 mg daily.
Effects on Lactation and Breastmilk
In 15 postmenopausal hypertensive women (prior lactation status not stated), serum prolactin levels were decreased by 22% compared to placebo after enalapril 20 mg once daily for 15 days. The maternal prolactin level in a mother with established lactation may not affect her ability to breastfeed.
A woman with pre-eclampsia was treated was started at term with oral enalapril 10 mg daily. Her milk came in on day 3 postpartum and she had no difficulties with nursing during 5 weeks of observation.
Alternate Drugs to Consider
1. Huttunen K, Gronhagen-Riska C, Fyhrquist F. Enalapril treatment of a nursing mother with slightly impaired renal function. Clin Nephrol. 1989;31:278. Letter. PMID: 2544326
2. Rush JE, Snyder DL, Barrish A et al. Comment on Huttunen K, Gronhagen-Riska C, Fyrquist F. Enalapril treatment of a nursing mother with slightly impaired renal function. Clin Nephrol. 1989;31:278. Clin Nephrol. 1991;35:234. Letter. PMID: 1649713
3. Redman CWG, Kelly JG, Cooper WD. The excretion of enalapril and enalaprilat in human breast milk. Eur J Clin Pharmacol. 1990;38:99. PMID: 2158450
4. Lombardi C, Missale C, De Cotiis R et al. Enalapril decreases plasma prolactin levels in hypertensive patients. J Biol Regul Homeost Agents. 1989;3:128-30. PMID: 2560316
5. Bach N. [Enalapril treatment of a pre-eclamptic woman]. Ugeskr Laeger. 1995;157:1203-4. PMID: 7701668
CAS Registry Number
Angiotensin-Converting Enzyme Inhibitors
LactMed Record Number
Last Revision Date
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.